Pharmaceutical News

RSS

Vax-Hub to influenze radical change in development and manufacturing of vaccines

Vax-Hub, a new Future Vaccine Manufacturing Research Hub, will bring together academia, industry and policy makers to affect radical change in the development and manufacturing of vaccines and improve responses to outbreaks of deadly pandemics such as Swine Flu and Ebola.

20 Sep 2018

ALSAM Foundation invests additional $2 million for drug discovery and development projects

The ALSAM Foundation recently invested an additional $2 million to continue the Therapeutic Innovation Grants Program at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences.

20 Sep 2018

Celltrion and Emory University sign 'Incubation' agreement to develop new drug candidates for atherosclerosis

Celltrion, Inc. signed an 'Incubation' agreement with Emory University in Atlanta to support the research and development of new drug candidates for atherosclerosis.

20 Sep 2018

Cannabinoid drugs reduce perceived unpleasantness of painful stimuli and increase tolerance

Researchers in the College of Arts and Sciences have determined that cannabinoid drugs do not appear to reduce the intensity of experimental pain, but, instead, may make pain feel less unpleasant and more tolerable.

19 Sep 2018

Study: Infants using popular anti-reflux medicines are not at increased risk of lung infections

New University of Otago research shows infants using popular anti-reflux medicines like omeprazole are not at increased risk of pneumonia or other lower respiratory tract infections, contrary to findings from other international studies.

19 Sep 2018

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Exelixis, Inc. today announced that its partner Ipsen Biopharmaceuticals Canada Inc. received approval from Health Canada of CABOMETYX® tablets for the treatment of adults with advanced renal cell carcinoma who have received prior vascular endothelial growth factor targeted therapy.

19 Sep 2018

UTILITY receives FDA approval for Investigational New Drug applications

UTILITY therapeutics Ltd, a pharmaceutical company focused on developing and commercializing antibiotics in the US, today announces that the US Food and Drug Administration has approved the Investigational New Drug applications for mecillinam and pivmecillinam.

19 Sep 2018

Analysis does not find any safety concerns of bivalent HPV vaccine

Infection with human papillomavirus can cause certain cancers in women and men, but HPV vaccines are highly effective in preventing infection with oncogenic HPV types.

19 Sep 2018

Researchers harness Zika virus vaccine under development to target glioblastoma

Researchers at The University of Texas Medical Branch at Galveston have successfully harnessed a Zika virus vaccine under development to target and kill the brain cancer known as glioblastoma.

19 Sep 2018

FDA takes new steps to address opioid crisis by approving Opioid Analgesic Risk Evaluation and Mitigation Strategy

Today, the U.S. Food and Drug Administration took new steps as part of its broader efforts to address the opioid crisis by approving the final Opioid Analgesic Risk Evaluation and Mitigation Strategy.

19 Sep 2018

New Crest Gum & Enamel Repair toothpaste may boost enamel repair and reverse gingivitis

According to data from the Centers for Disease Control and Prevention, nearly half of U.S. adults have gum disease. Harmful plaque bacteria can hide in crevices below the gum line.

18 Sep 2018

New compound could prevent malaria parasites from maturing inside mosquito

Researchers have identified compounds that could prevent malaria parasites from being able to infect mosquitoes, halting the spread of disease.

18 Sep 2018

Muscle relaxants used during general anesthesia can increase risk of pulmonary complications

Muscle relaxants that are used during general anesthesia increase the risk of pulmonary complications after surgery, according to the European milicenter study POPULAR, in which Karolinska Institutet researchers are involved. The study is published in the journal Lancet Respiratory Medicine.

18 Sep 2018

LEO Pharma and MorphoSys announce expansion of strategic alliance to develop peptide-derived drugs

LEO Pharma A/S, a global leader in medical dermatology, and MorphoSys AG today announced an expansion of their existing strategic alliance to include peptide-derived therapeutics.

18 Sep 2018

Alcon expands its global support of eye care professionals through Alcon Experience Academy

Alcon, the global leader in eye care and a division of Novartis, is expanding its extensive, global support of eye care professionals through the unveiling of the Alcon Experience Academy.

18 Sep 2018

Resveratrol decreases pain severity and levels of inflammatory biomarkers in osteoarthritis patients

In what researchers state is the first pilot clinical trial to assess the effects of resveratrol on pain severity and levels of inflammatory biomarkers in patients with mild to moderate knee osteoarthritis, the scientists compared treatment with a nonsteroidal anti-inflammatory drug combined with either resveratrol or placebo over 90 days.

18 Sep 2018

ASPREE trial explores whether low dose aspirin can prolong good health in elderly people

The ASPREE trial of more than 19,000 participants in Australia and the US is the largest and most comprehensive study to look at whether the many millions of older people around the world who take (100mg) low dose aspirin to preserve good health are deriving any benefit by doing so.

18 Sep 2018

Study confirms link between use of muscle relaxants and respiratory complications

Muscle relaxants are a necessary part of anesthesia during certain major operations. Studies have, however, hinted at respiratory risks connected with these drugs.

17 Sep 2018

Probiotic supplementation may reduce use of antibiotics, scientific analysis shows

Global demand exists for new ways to reduce antibiotic use, given the urgent public health threat of antibiotic resistance.

17 Sep 2018

Daily low-dose aspirin does not prolong healthy life in older people, study finds

In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living (life free of dementia or persistent physical disability).

17 Sep 2018

Pharmaceutical News

Vax-Hub to influenze radical change in development and manufacturing of vaccines

ALSAM Foundation invests additional $2 million for drug discovery and development projects

Celltrion and Emory University sign 'Incubation' agreement to develop new drug candidates for atherosclerosis

Cannabinoid drugs reduce perceived unpleasantness of painful stimuli and increase tolerance

Study: Infants using popular anti-reflux medicines are not at increased risk of lung infections

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

UTILITY receives FDA approval for Investigational New Drug applications

Analysis does not find any safety concerns of bivalent HPV vaccine

Researchers harness Zika virus vaccine under development to target glioblastoma

FDA takes new steps to address opioid crisis by approving Opioid Analgesic Risk Evaluation and Mitigation Strategy

New Crest Gum & Enamel Repair toothpaste may boost enamel repair and reverse gingivitis

New compound could prevent malaria parasites from maturing inside mosquito

Muscle relaxants used during general anesthesia can increase risk of pulmonary complications

LEO Pharma and MorphoSys announce expansion of strategic alliance to develop peptide-derived drugs

Alcon expands its global support of eye care professionals through Alcon Experience Academy

Resveratrol decreases pain severity and levels of inflammatory biomarkers in osteoarthritis patients

ASPREE trial explores whether low dose aspirin can prolong good health in elderly people

Study confirms link between use of muscle relaxants and respiratory complications

Probiotic supplementation may reduce use of antibiotics, scientific analysis shows

Daily low-dose aspirin does not prolong healthy life in older people, study finds

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News